ArticleTherapeutic advances in medical oncology2022

Durable benefit and change in TCR clonality with nivolumab in a Lynch syndrome-associated glioma.

Santiago Cabezas-Camarero et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.